UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
6-K
REPORT
OF FOREIGN PRIVATE ISSUER
PURSUANT
TO RULE 13a-16 OR 15d-16
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For
the month of September 2025
Commission
File Number: 001-42669
PITANIUM
LIMITED
(Registrant’s
Name)
30F,
Gravity, 29 Hing Yip Street,
Kwun
Tong, Kowloon, Hong Kong
(Address
of principal executive offices)
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Information
Contained in this Form 6-K Report
Pitanium
Limited (“Pitanium”) and its subsidiary (collectively, the “Company”) is furnishing this Form 6-K to provide
six-month interim financial statements.
Special
Note Regarding Forward-Looking Statements
Statements
in this current report with respect to the Company’s current plans, estimates, strategies, beliefs and other statements that are
not historical facts are forward-looking statements about the future performance of the Company. Forward-looking statements include,
but are not limited to, those statements using words such as “believe,” “expect,” “plans,” “strategy,”
“prospects,” “forecast,” “estimate,” “project,” “anticipate,” “aim,”
“intend,” “seek,” “may,” “might,” “could” or “should,” and words
of similar meaning in connection with a discussion of future operations, financial performance, events, or conditions. From time to time,
oral or written forward-looking statements may also be included in other materials released to the public. These statements are based
on management’s assumptions, judgments, and beliefs in light of the information currently available to it. The Company cautions
investors that a number of important risks and uncertainties could cause actual results to differ materially from those discussed in
the forward-looking statements, including but not limited to, product and service demand and acceptance, changes in technology, economic
conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with
the U.S. Securities and Exchange Commission. Therefore, investors should not place undue reliance on such forward-looking statements.
Actual results may differ significantly from those set forth in the forward-looking statements.
All
such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by
the cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, the Company
disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Financial
Statements and Exhibits.
Exhibits:
| Exhibit
No. |
|
Description |
| 99.1 |
|
Unaudited Interim Consolidated Financial Statements as of March 31, 2025 and for the Six Months Ended March 31, 2025 and 2024 |
| 99.2 |
|
Operating and Financial Review in Connection with the Unaudited Interim Consolidated Financial Statements for the Six Months Ended March 31, 2025 and 2024 |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
| Date:
September 15, 2025 |
Pitanium
Limited |
| |
|
|
| |
By: |
/s/
Ying Yeung Wong |
| |
Name:
|
Ying
Yeung Wong |
| |
Title: |
Chief
Executive Officer and Director |
